1) Chugani DC, Muzik O, Behen M, et al:Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol 45:287-295, 1999
2) 橋本謙二,Joseph Zohar,福田正人:強迫性障害に対する薬物療法.臨精薬理 12:781-790,2009
3) Hesse S, Müller U, Lincke T, et al:Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder. Psychiatry Res 140:63-72, 2005
4) Ishima T, Fujita Y, Kohno M, et al:Improvement of phencyclidine-induced cognitive deficits in mice by subsequent subchronic administration of fluvoxamine, but not sertraline. The Open Clin Chem J 2:7-11, 2009
5) 松原敏郎,西村理,牧原浩,他:低用量のfluvoxamineが関連症状ならびに対人関係障害の一部に有効であった小児自閉性障害の2症例.精神科治療学 20:323-329,2005
6) McElroy SL, Phillips KA, Keck PE Jr:Obsessive compulsive spectrum disorder. J Clin Psychiatry 55 (Suppl):33-51, 1994
7) Ohnishi T, Matsuda H, Hashimoto T, et al:Abnormal regional cerebral blood flow in childhood autism. Brain 123:1838-1844, 2000
8) Stahl SM 著,仙波純一 訳:精神薬理学エセンシャルズ.メディカルサイエンスインターナショナル,pp263-268,2002
9) 杉田完爾:異食症(pica)の病態とその対策.日本臨牀 59:561-565, 2001
10) 高橋三郎,大野裕,染矢俊幸 訳:DSM-Ⅳ精神疾患の分類と診断の手引き.医学書院,1995
11) Takebayashi M, Hayashi T, Su TP:Nerve growth factor-induced neurite sprouting in PC12 cells involves sigma-1 receptors:Implications for antidepressants. J Pharmacol Exp Ther 303:1227-1237, 2002